---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-099649"
form_type: "8-K"
ticker: "CTXR"
cik: "0001506251"
company_name: "Citius Pharmaceuticals, Inc."
filed_at: "2024-11-18T23:59:59+00:00"
generated_at: "2026-05-29T22:59:38.757259+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Citius Pharma raises $3M in registered direct offering of 12M shares and 12M warrants

## Summary
- Offering consists of 12M common shares and warrants for 12M shares at combined $0.25; gross proceeds $3.0M.
- Net proceeds approx. $2.7M after fees; intended for R&D, working capital, and general corporate purposes.
- Warrants exercisable at $0.25 per share, immediately exercisable, expire in 5 years; cashless exercise if no effective registration.
- Placement agent H.C. Wainwright receives 7% cash fee plus 840,000 placement agent warrants at $0.3125 per share.
- Closing occurred November 18, 2024; offering made under existing effective shelf registration (File No. 333-277319).

## SEC filing metadata
- accession: 0001213900-24-099649
- form_type: 8-K
- ticker: CTXR
- cik: 0001506251
- company_name: Citius Pharmaceuticals, Inc.
- filed_at: 2024-11-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506251/000121390024099649/0001213900-24-099649-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506251/000121390024099649/ea0221547-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-099649
- JSON: https://secwatch.observer/filing/0001213900-24-099649.json
- Plain text: https://secwatch.observer/filing/0001213900-24-099649.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.